Engage, Integra raise venture financings

Epilepsy play Engage Therapeutics Inc. (Summit, N.J.) and life science investment company Integra Holdings (Jerusalem, Israel) announced venture financings, raising nearly $50 million.

Engage raised $23 million on Sept. 27 in a series A round led by TPG Biotech, with participation from fellow new investors Adage Capital Management and Lumira Capital. President and CEO Gregory Mayes told BioCentury he expects funds to last through 2019...